BMS	bare metal stents
BP	biodegradable polymer
CI	confidence interval
CoCr	cobalt-chromium
CTO	chronic total occlusions
DES	drug-eluting stents
DOCE	device-oriented composite endpoint
DP	durable polymer
EES	everolimus-eluting stent
HBR	high bleeding risk
LLL	late lumen loss
MACE	major adverse cardiac events
MI	myocardial infarction
PCI	percutaneous coronary interventions
PLGA	poly-d,l-lactide-co-glycolide
PLLA	poly-l-lactic acid
PtCR	platinum-chromium
SES	sirolimus-eluting stent
ST	stent thrombosis
STEMI	ST-segment elevation myocardial infarction
TLF	target-lesion failure
TLR	target-lesion revascularization
TVF	target-vessel failure
TV-MI	target-vessel myocardial infarction
ZES	zotarolimus-eluting stent.